{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:03:08Z","timestamp":1791514988459,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T00:00:00Z","timestamp":1296259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00259-010-1720-x","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T12:21:11Z","timestamp":1296217271000},"page":"865-873","source":"Crossref","is-referenced-by-count":119,"title":["Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine"],"prefix":"10.1007","volume":"38","author":[{"given":"Alexander","family":"Kroiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Putzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Uprimny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Decristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Santner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Kranewitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Warwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Waitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Johanna","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,29]]},"reference":[{"key":"1720_CR1","first-page":"1635","volume":"47","author":"C Franzius","year":"2006","unstructured":"Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, et al. Whole-body PET\/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT\/CT. J Nucl Med. 2006;47:1635\u201342.","journal-title":"J Nucl Med"},{"key":"1720_CR2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2214\/ajr.181.4.1811115","volume":"181","author":"T Pfluger","year":"2003","unstructured":"Pfluger T, Schmied C, Porn U, Leinsinger G, Vollmar C, Dresel S, et al. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma. AJR Am J Roentgenol. 2003;181:1115\u201324.","journal-title":"AJR Am J Roentgenol"},{"key":"1720_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/jc.2003-031091","volume":"89","author":"I Ilias","year":"2004","unstructured":"Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab. 2004;89:479\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"1720_CR4","first-page":"1172","volume":"45","author":"BH Kushner","year":"2004","unstructured":"Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172\u201388.","journal-title":"J Nucl Med"},{"key":"1720_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","volume":"4","author":"I Brink","year":"2005","unstructured":"Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer. 2005;4:61\u20138.","journal-title":"Fam Cancer"},{"key":"1720_CR6","first-page":"328","volume":"30","author":"MG Velchik","year":"1989","unstructured":"Velchik MG, Alavi A, Kressel HY, Engelman K. Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation. J Nucl Med. 1989;30:328\u201336.","journal-title":"J Nucl Med"},{"key":"1720_CR7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O\u2019Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50:1448\u201354.","journal-title":"J Nucl Med"},{"key":"1720_CR8","first-page":"1352","volume":"38","author":"A Leung","year":"1997","unstructured":"Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med. 1997;38:1352\u20137.","journal-title":"J Nucl Med"},{"key":"1720_CR9","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1200\/JCO.2008.20.5732","volume":"27","author":"DR Taggart","year":"2009","unstructured":"Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol. 2009;27:5343\u20139.","journal-title":"J Clin Oncol"},{"key":"1720_CR10","first-page":"217","volume":"43","author":"JC Sisson","year":"1999","unstructured":"Sisson JC, Shulkin BL. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med. 1999;43:217\u201323.","journal-title":"Q J Nucl Med"},{"key":"1720_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","volume":"24","author":"JC Reubi","year":"2003","unstructured":"Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev. 2003;24:389\u2013427.","journal-title":"Endocr Rev."},{"key":"1720_CR12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/1096-911X(20001201)35:6<688::AID-MPO44>3.0.CO;2-7","volume":"35","author":"FH Schilling","year":"2000","unstructured":"Schilling FH, Bihl H, Jacobsson H, Ambros PF, Martinsson T, Borgstr\u00f6m P, et al. Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information. Med Pediatr Oncol. 2000;35:688\u201391.","journal-title":"Med Pediatr Oncol"},{"key":"1720_CR13","first-page":"1","volume":"36","author":"F Tenenbaum","year":"1995","unstructured":"Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, et al. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med. 1995;36:1\u20136.","journal-title":"J Nucl Med"},{"key":"1720_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jc.86.2.685","volume":"86","author":"E Harst van der","year":"2001","unstructured":"van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, et al. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab. 2001;86:685\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"1720_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","volume":"222","author":"S Hoegerle","year":"2002","unstructured":"Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: detection with 18F DOPA whole body PET \u2013 initial results. Radiology. 2002;222:507\u201312.","journal-title":"Radiology"},{"key":"1720_CR16","first-page":"561","volume":"21","author":"CA Hoefnagel","year":"1994","unstructured":"Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med. 1994;21:561\u201381.","journal-title":"Eur J Nucl Med"},{"key":"1720_CR17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MNM.0b013e3282f1753d","volume":"28","author":"C Decristoforo","year":"2007","unstructured":"Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, et al. A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun. 2007;28:870\u20135.","journal-title":"Nucl Med Commun"},{"key":"1720_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00259-002-1027-7","volume":"30","author":"E Bombardieri","year":"2003","unstructured":"Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, et al. 131I\/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:132\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1720_CR19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00259-007-0370-0","volume":"34","author":"M Lassmann","year":"2007","unstructured":"Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34:796\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1720_CR20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3413\/nukmed-0311","volume":"47","author":"C Franzius","year":"2008","unstructured":"Franzius C, Schmidt M, Hero B, Pfluger T, Hahn K; Deutsche Gesellschaft f\u00fcr Nuklearmedizin (DGN); Neuroblastom-Studiengruppe der Gesellschaft f\u00fcr P\u00e4diatrische Onkologie und H\u00e4matologie (GPOH). Procedure guidelines for MIBG-scintigraphy in children. Nuklearmediziner. 2008;47:132\u20138.","journal-title":"Nuklearmediziner"},{"key":"1720_CR21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","volume":"49","author":"I Ilias","year":"2008","unstructured":"Ilias I, Chen CC, Carrasquillo JA, Whatley M, Ling A, Laz\u00farov\u00e1 I, et al. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med. 2008;49:1613\u20139.","journal-title":"J Nucl Med"},{"key":"1720_CR22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2214\/AJR.07.2107","volume":"190","author":"K Rozovsky","year":"2008","unstructured":"Rozovsky K, Koplewitz BZ, Krausz Y, Revel-Vilk S, Weintraub M, Chisin R, et al. Added value of SPECT\/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. AJR Am J Roentgenol. 2008;190:1085\u201390.","journal-title":"AJR Am J Roentgenol"},{"key":"1720_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000184855","volume":"90","author":"A Sundin","year":"2009","unstructured":"Sundin A, Vullierme MP, Kaltsas G, Pl\u00f6ckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. Neuroendocrinology. 2009;90:167\u201383.","journal-title":"Neuroendocrinology"},{"key":"1720_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejrad.2009.09.014","volume":"75","author":"HW Goo","year":"2010","unstructured":"Goo HW. Whole-body MRI of neuroblastoma. Eur J Radiol. 2009;75:306\u201314","journal-title":"Eur J Radiol"},{"key":"1720_CR25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.199.3.8637999","volume":"199","author":"BL Shulkin","year":"1996","unstructured":"Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology. 1996;199:743\u201350.","journal-title":"Radiology"},{"key":"1720_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","volume":"212","author":"BL Shulkin","year":"1999","unstructured":"Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology. 1999;212:35\u201341.","journal-title":"Radiology"},{"key":"1720_CR27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.rlu.0000170060.52675.14","volume":"30","author":"S Ezuddin","year":"2005","unstructured":"Ezuddin S, Fragkaki C. MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy. Clin Nucl Med. 2005;30:579\u201381.","journal-title":"Clin Nucl Med"},{"key":"1720_CR28","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","volume":"25","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol. 2007;25:2262\u20139.","journal-title":"J Clin Oncol"},{"key":"1720_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2006.12.003","volume":"21","author":"A Sundin","year":"2007","unstructured":"Sundin A, Garske U, Orlefors H. Nuclear imaging of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21:69\u201385.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1720_CR30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508\u201318.","journal-title":"J Nucl Med"},{"key":"1720_CR31","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2967\/jnumed.108.060236","volume":"50","author":"D Putzer","year":"2009","unstructured":"Putzer D, Gabriel M, Henninger B, Kendler D, Uprimny C, Dobrozemsky G, et al. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med. 2009;50:1214\u201321.","journal-title":"J Nucl Med"},{"key":"1720_CR32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2967\/jnumed.108.058396","volume":"50","author":"F Imani","year":"2009","unstructured":"Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, et al. 18F-FDOPA PET and PET\/CT accurately localize pheochromocytomas. J Nucl Med. 2009;50:513\u20139.","journal-title":"J Nucl Med"},{"key":"1720_CR33","first-page":"68","volume":"54","author":"D Putzer","year":"2010","unstructured":"Putzer D, Gabriel M, Kendler D, Henninger B, Knoflach M, Kroiss A, et al. Comparison of 68Ga-DOTA-Tyr3-octreotide and 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients. Q J Nucl Med Mol Imaging. 2010;54:68\u201375.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1720_CR34","first-page":"102","volume":"12","author":"M Pagou","year":"2009","unstructured":"Pagou M, Zerizer I, Al-Nahhas A. Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging? Hell J Nucl Med. 2009;12:102\u20135.","journal-title":"Hell J Nucl Med"},{"key":"1720_CR35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.semnuclmed.2007.02.009","volume":"37","author":"R Howman-Giles","year":"2007","unstructured":"Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med. 2007;37:286\u2013302.","journal-title":"Semin Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1720-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1720-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1720-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T01:52:41Z","timestamp":1559958761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1720-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,29]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1720-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,29]]}}}